21.218 articles found

Pergolide in the treatment of Parkinson's disease.

Mizuno Y, Kondo T, Narabayashi H.

Neurology · 1995-03-01

DOI: 10.1212/wnl.45.3_suppl_3.s13PMID: 7715792

A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.

Pezzoli G, Martignoni E, Pacchetti C, Angeleri V, Lamberti P, Muratorio A, Bonuccelli U, De Mari M, Foschi N, Cossutta E.

Neurology · 1995-03-01

DOI: 10.1212/wnl.45.3_suppl_3.s22PMID: 7715793

Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.

Kobari M, Fukuuchi Y, Shinohara T, Obara K, Nogawa S.

J Neurol Sci · 1995-02-01

DOI: 10.1016/0022-510x(94)00237-iPMID: 7738597

Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine.

Meltzer HY, Kennedy J, Dai J, Parsa M, Riley D.

Neuropsychopharmacology · 1995-02-01

DOI: 10.1016/0893-133x(94)00060-dPMID: 7766285

High levodopa use in periodically time-clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology? Europarkinson Preparatory Activity Research Group.

de Pedro-Cuesta J, Petersen IJ, Stawiarz L, Gudmundsson G, Gudmundsson G, Almazán J, Tulinius H, Johansson H.

Acta Neurol Scand · 1995-02-01

DOI: 10.1111/j.1600-0404.1995.tb00412.xPMID: 7785429

Profound hypotension immediately following insertion of methyl methacrylate during bipolar endoprosthesis in a patient with long-term levodopa-treated paralysis agitans.

Kim YC, Cho MS, Kim SS, Kim SY, Lee YG, Kim TH, Jung SR.

J Korean Med Sci · 1995-02-01

DOI: 10.3346/jkms.1995.10.1.31PMID: 7598821

Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.

Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.

Psychopharmacology (Berl) · 1995-02-01

DOI: 10.1007/bf02246211PMID: 7604140

Long-term outcome of operative treatment of focal atrial tachycardia.

Misaki T, Watanabe G, Iwa T, Ishida K, Tsubota M, Matsunaga Y, Watanabe Y, Fujiki A, Inoue H, Okada R.

J Am Coll Surg · 1995-02-01

PMID: 7850044

Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism.

Shults CW, Nasirian F, Ward DM, Nakano K, Pay M, Hill LR, Haas RH.

Neurology · 1995-02-01

DOI: 10.1212/wnl.45.2.344PMID: 7854537

Lack of a detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease.

Ansari AA, Mayne A, Freed CR, Breeze RE, Schneck SA, O'Brien CF, Kriek EH, Zhang YB, Mazziotta JC, Hutchinson M.

Transplant Proc · 1995-02-01

PMID: 7878926

Dopaminergic neurotrofic factors gene therapy for parkinson's disease in future

Chen Qian, Yu Yun-Ka, Wang Jia-Zheng.

Zhongguo shen jing ke xue za zhi = Chinese journal of neuroscience · 1995-01-01

[A pharmacological study of levodopa solution therapy for a patient with Parkinson's disease with motor fluctuations].

Ishikura N, Hamamoto M, Ohtsubo K, Miyazaki T.

Nihon Ronen Igakkai Zasshi · 1995-01-01

DOI: 10.3143/geriatrics.32.51PMID: 7739145